Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Choquet

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Bulletin Du Cancer|January 28, 2009
[Chronic lymphoproliferative disease in the elderly]Sylvain Choquet
Current Oncology Reports|October 28, 2024
CAR T-cell Therapy for Central Nervous System LymphomaCaroline Houillier, Sylvain Choquet
Seminars in Oncology|April 30, 2003
Fludarabine in Waldenstrom's macroglobulinemiaVéronique Leblond, Sylvain Choquet
Bulletin Du Cancer|July 10, 2004
[Identification of prognostic factors in post-transplantation lymphoproliferative disorders]Sylvain Choquet, Vincent Levy, Véronique Leblond
Journal of Clinical Apheresis|April 30, 2017
Impact of plerixafor (mozobil) on hospital efficiency: A single center experienceNabih Azar, Maya Ouzegdouh, Sylvain Choquet, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2013
Primary therapy of Waldenström macroglobulinemia with nucleoside analogue-based therapyLaetitia Souchet-Compain, Stéphanie Nguyen, Sylvain Choquet, et al.
Expert Review of Hematology|June 21, 2013
Fludarabine in Waldenstrom's macroglobulinemiaLaetitia Souchet-Compain, Stéphanie Nguyen, Sylvain Choquet, et al.
Bulletin De L'Academie Nationale De Medecine|February 3, 2010
[Monoclonal gammapathy: when does the hematologist need the neurologist's help?]Véronique Leblond, Marie Anne Hospital, Andréa Toma, et al.
Bulletin Du Cancer|April 3, 2014
[Primary CNS lymphoma--an update]Carole Soussain, Caroline Houillier, Sylvain Choquet, et al.
Immunotherapy|April 26, 2014
Current and future therapeutic approach for Waldenström's macroglobulinemiaLaetitia Souchet-Cömpain, Sylvain Choquet, Véronique Leblond, et al.
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Bulletin Du Cancer|January 28, 2009
[Chronic lymphoproliferative disease in the elderly]Sylvain Choquet
Current Oncology Reports|October 28, 2024
CAR T-cell Therapy for Central Nervous System LymphomaCaroline Houillier, Sylvain Choquet
Seminars in Oncology|April 30, 2003
Fludarabine in Waldenstrom's macroglobulinemiaVéronique Leblond, Sylvain Choquet
Bulletin Du Cancer|July 10, 2004
[Identification of prognostic factors in post-transplantation lymphoproliferative disorders]Sylvain Choquet, Vincent Levy, Véronique Leblond
Journal of Clinical Apheresis|April 30, 2017
Impact of plerixafor (mozobil) on hospital efficiency: A single center experienceNabih Azar, Maya Ouzegdouh, Sylvain Choquet, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2013
Primary therapy of Waldenström macroglobulinemia with nucleoside analogue-based therapyLaetitia Souchet-Compain, Stéphanie Nguyen, Sylvain Choquet, et al.
Expert Review of Hematology|June 21, 2013
Fludarabine in Waldenstrom's macroglobulinemiaLaetitia Souchet-Compain, Stéphanie Nguyen, Sylvain Choquet, et al.
Bulletin De L'Academie Nationale De Medecine|February 3, 2010
[Monoclonal gammapathy: when does the hematologist need the neurologist's help?]Véronique Leblond, Marie Anne Hospital, Andréa Toma, et al.
Bulletin Du Cancer|April 3, 2014
[Primary CNS lymphoma--an update]Carole Soussain, Caroline Houillier, Sylvain Choquet, et al.
Immunotherapy|April 26, 2014
Current and future therapeutic approach for Waldenström's macroglobulinemiaLaetitia Souchet-Cömpain, Sylvain Choquet, Véronique Leblond, et al.
Pageof 18